Correlation Between Protagenic Therapeutics and Protagonist Therapeutics

Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and Protagonist Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and Protagonist Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protagenic Therapeutics and Protagonist Therapeutics, you can compare the effects of market volatilities on Protagenic Therapeutics and Protagonist Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of Protagonist Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and Protagonist Therapeutics.

Diversification Opportunities for Protagenic Therapeutics and Protagonist Therapeutics

0.32

Correlation Coefficient

Protagenic Therapeutics  Protagonist Therapeutics

Weak diversification

The 3 months correlation between Protagenic and Protagonist is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and Protagonist Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagonist Therapeutics and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with Protagonist Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagonist Therapeutics has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and Protagonist Therapeutics go up and down completely randomly.

Pair Corralation between Protagenic Therapeutics and Protagonist Therapeutics

Given the investment horizon of 90 days Protagenic Therapeutics is expected to under-perform the Protagonist Therapeutics. In addition to that, Protagenic Therapeutics is 3.93 times more volatile than Protagonist Therapeutics. It trades about -0.06 of its total potential returns per unit of risk. Protagonist Therapeutics is currently generating about -0.18 per unit of volatility. If you would invest  4,553  in Protagonist Therapeutics on September 25, 2024 and sell it today you would lose (404.00) from holding Protagonist Therapeutics or give up 8.87% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Protagenic Therapeutics  vs.  Protagonist Therapeutics

Protagenic Therapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Protagenic Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Protagenic Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Protagonist Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Protagonist Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's technical and fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Protagenic Therapeutics and Protagonist Therapeutics

The main advantage of trading using opposite Protagenic Therapeutics and Protagonist Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, Protagonist Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagonist Therapeutics will offset losses from the drop in Protagonist Therapeutics' long position.

The idea behind Protagenic Therapeutics and Protagonist Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.